Andras G. Lacko

3.8k total citations
122 papers, 3.1k citations indexed

About

Andras G. Lacko is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Andras G. Lacko has authored 122 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 55 papers in Surgery and 34 papers in Cancer Research. Recurrent topics in Andras G. Lacko's work include Cholesterol and Lipid Metabolism (42 papers), Cancer, Lipids, and Metabolism (24 papers) and Lipoproteins and Cardiovascular Health (23 papers). Andras G. Lacko is often cited by papers focused on Cholesterol and Lipid Metabolism (42 papers), Cancer, Lipids, and Metabolism (24 papers) and Lipoproteins and Cardiovascular Health (23 papers). Andras G. Lacko collaborates with scholars based in United States, Canada and Netherlands. Andras G. Lacko's co-authors include Nirupama Sabnis, Walter J. McConathy, Maya Nair, Linda Mooberry, Louis A. Soloff, Bhalchandra J. Kudchodkar, Sulabha Paranjape, Huanbiao Mo, R.W. Gracy and B.L. Horecker and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Andras G. Lacko

121 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andras G. Lacko United States 29 1.3k 1.0k 855 530 393 122 3.1k
Christophe Blanquart France 26 1.6k 1.2× 584 0.6× 376 0.4× 321 0.6× 103 0.3× 80 2.9k
Uwe Michaelis Germany 33 1.7k 1.3× 328 0.3× 365 0.4× 572 1.1× 570 1.5× 62 4.1k
Cynthia Hong United States 39 2.2k 1.7× 1.8k 1.8× 802 0.9× 262 0.5× 142 0.4× 56 5.6k
Florence Lefranc Belgium 42 2.5k 1.9× 550 0.5× 545 0.6× 307 0.6× 272 0.7× 108 6.3k
Srigiridhar Kotamraju India 37 2.4k 1.8× 315 0.3× 524 0.6× 168 0.3× 204 0.5× 82 5.3k
Jean‐Claude Mazière France 33 1.8k 1.4× 361 0.4× 618 0.7× 256 0.5× 52 0.1× 142 4.1k
Yasuko Iwakiri United States 40 1.3k 1.0× 1.3k 1.3× 269 0.3× 268 0.5× 134 0.3× 87 5.2k
Borhane Annabi Canada 41 2.2k 1.6× 460 0.5× 1.2k 1.4× 118 0.2× 207 0.5× 151 4.8k
Ebbe Boedtkjer Denmark 28 1.7k 1.3× 237 0.2× 649 0.8× 123 0.2× 228 0.6× 73 2.9k
Maryvonne Rosseneu Belgium 32 2.3k 1.8× 1.2k 1.2× 425 0.5× 1.0k 1.9× 132 0.3× 88 3.9k

Countries citing papers authored by Andras G. Lacko

Since Specialization
Citations

This map shows the geographic impact of Andras G. Lacko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andras G. Lacko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andras G. Lacko more than expected).

Fields of papers citing papers by Andras G. Lacko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andras G. Lacko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andras G. Lacko. The network helps show where Andras G. Lacko may publish in the future.

Co-authorship network of co-authors of Andras G. Lacko

This figure shows the co-authorship network connecting the top 25 collaborators of Andras G. Lacko. A scholar is included among the top collaborators of Andras G. Lacko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andras G. Lacko. Andras G. Lacko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabnis, Nirupama, et al.. (2025). Biodistribution of Reconstituted High-Density Lipoprotein Nanoparticles for Targeted Delivery to Retinal Ganglion Cells. Journal of Ocular Pharmacology and Therapeutics. 41(5). 281–289.
2.
Sabnis, Nirupama, Rafał Fudala, Andras G. Lacko, et al.. (2025). Fluorescence Resonance Energy Transfer for Drug Loading Assessment in Reconstituted High-Density Lipoprotein Nanoparticles. International Journal of Molecular Sciences. 26(7). 3276–3276. 1 indexed citations
3.
4.
5.
Raut, Sangram, B. Nagarajan, Nirupama Sabnis, et al.. (2020). Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence. Journal of Pharmacology and Experimental Therapeutics. 373(1). 113–121. 6 indexed citations
6.
Raut, Sangram, et al.. (2018). Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. Frontiers in Pharmacology. 9. 1154–1154. 48 indexed citations
7.
Sabnis, Nirupama, et al.. (2017). Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles. Nanotheranostics. 1(4). 440–449. 21 indexed citations
8.
Mooberry, Linda, et al.. (2016). Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Frontiers in Pharmacology. 7. 466–466. 106 indexed citations
9.
Mooberry, Linda, Maya Nair, Sulabha Paranjape, Walter J. McConathy, & Andras G. Lacko. (2009). Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. Journal of drug targeting. 18(1). 53–58. 107 indexed citations
10.
Kálmán, János, Bhalchandra J. Kudchodkar, Raghu R. Krishnamoorthy, et al.. (2001). High cholesterol diet down regulates the activity of activator protein-1 but not nuclear factor-kappa B in rabbit brain. Life Sciences. 68(13). 1495–1503. 14 indexed citations
11.
Lacko, Andras G., et al.. (2000). Comparison of pharmacological and clinical activity between cisplatin and carboplatin in the treatment of solid tumours. Nowotwory Journal of Oncology. 50(6). 609–609. 5 indexed citations
12.
Lacko, Andras G., Andrew J. Reason, Colin Nuckolls, et al.. (1998). Characterization of recombinant human plasma lecithin: cholesterol acyltransferase (LCAT): N-linked carbohydrate structures and catalytic properties. Journal of Lipid Research. 39(4). 807–820. 12 indexed citations
13.
Fungwe, Thomas V., Bhalchandra J. Kudchodkar, Andras G. Lacko, & Ladislav Dory. (1997). The expression of lecithin:Cholesterol acyltransferase is influenced by diet. The FASEB Journal. 11(3). 1 indexed citations
14.
Lacko, Andras G., et al.. (1992). Physiologic role and clinical significance of reverse cholesterol transport. The Journal of the American Osteopathic Association. 92(5). 625–632. 6 indexed citations
15.
Pritchard, P. Haydn, et al.. (1988). Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease). Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 958(2). 227–234. 22 indexed citations
16.
Albers, John J., et al.. (1986). Isolation, characterization, and assay of lecithin-cholesterol acyltransferase. Methods in enzymology on CD-ROM/Methods in enzymology. 129. 763–783. 87 indexed citations
17.
Lacko, Andras G., et al.. (1980). A Novel Chromatographic Method for the Preparation of High Density Lipoproteins. Preparative Biochemistry. 10(4). 431–444. 13 indexed citations
18.
Lacko, Andras G. & Timothy F. Chen. (1977). Enzyme purification by affinity chromatography using a non-covalently bound adsorbent. Journal of Chromatography A. 130. 446–450. 5 indexed citations
19.
Rotenberg, Samuel, et al.. (1975). Regulation of Corticosterone Levels and Liver Enzyme Activity in Aging Rats. Advances in experimental medicine and biology. 61. 209–228. 16 indexed citations
20.
Lacko, Andras G., et al.. (1973). Measurement of the initial rate of serum cholesterol esterification. Biochemical Medicine. 7(1). 178–183. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Blanquart Breakdown of academic impact, for papers by Uwe Michaelis Breakdown of academic impact, for papers by Cynthia Hong Breakdown of academic impact, for papers by Florence Lefranc Breakdown of academic impact, for papers by Srigiridhar Kotamraju Breakdown of academic impact, for papers by Jean‐Claude Mazière Breakdown of academic impact, for papers by Yasuko Iwakiri Breakdown of academic impact, for papers by Borhane Annabi Breakdown of academic impact, for papers by Ebbe Boedtkjer Breakdown of academic impact, for papers by Maryvonne Rosseneu
Rankless by CCL
2026